(189) demonstrated EGFR-expression and EGFR-dependent activation of a CAF subtype in pancreatic cancer (the myofibroblastic CAFs, or myCAFs), promoting local metastasis. This evidence concerns the gene EGFR and familial pancreatic carcinoma.